Lynntech

The College Station, Texas-based firm is developing a multiplex, one-step system to diagnose all four dengue serotypes.

A former scientist from Texas-based R&D firm Lynntech who was developing a nucleic acid sample prep module intended for use with molecular diagnostic assays for resource-poor areas of the world has left the company and founded his own startup to commercialize an improved vers

The grants, awarded through the Qualifying Therapeutic Discovery Project Program created by the Patient Protection and Affordable Care Act of 2010, were disclosed last week by the IRS.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.